Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Following publication of the original article [1], the authors reported an error in their listed affiliations.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | http://link.springer.com/article/10.1186/s40425-018-0487-7 |
| id |
doaj-6f76a938d1904fb48158213cdb6d7994 |
|---|---|
| record_format |
Article |
| spelling |
doaj-6f76a938d1904fb48158213cdb6d79942020-11-25T01:37:57ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262019-01-01711110.1186/s40425-018-0487-7Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patientsBin Zhao0Hong Zhao1Jiaxin Zhao2The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical UniversityThe Third Affiliated Hospital of Harbin Medical UniversityThe Fourth Affiliated Hospital of Harbin Medical UniversityFollowing publication of the original article [1], the authors reported an error in their listed affiliations.http://link.springer.com/article/10.1186/s40425-018-0487-7 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Bin Zhao Hong Zhao Jiaxin Zhao |
| spellingShingle |
Bin Zhao Hong Zhao Jiaxin Zhao Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients Journal for ImmunoTherapy of Cancer |
| author_facet |
Bin Zhao Hong Zhao Jiaxin Zhao |
| author_sort |
Bin Zhao |
| title |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| title_short |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| title_full |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| title_fullStr |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| title_full_unstemmed |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| title_sort |
correction to: serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
| publisher |
BMJ Publishing Group |
| series |
Journal for ImmunoTherapy of Cancer |
| issn |
2051-1426 |
| publishDate |
2019-01-01 |
| description |
Following publication of the original article [1], the authors reported an error in their listed affiliations. |
| url |
http://link.springer.com/article/10.1186/s40425-018-0487-7 |
| work_keys_str_mv |
AT binzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients AT hongzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients AT jiaxinzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients |
| _version_ |
1725056147371589632 |